How We Work With Therapists & Healthcare Providers

In our experience, patients are best served when the all members of the provider team work together and are fully informed. We value your expertise and welcome the opportunity to support you and your patients.

Submit your referral

We Work With:

Psychiatrists
Therapists
Psychologists
Neurologists
Pain Specialists
Primary Care Physicians
Coaches
Social Workers

Treatments for:

Depression
Anxiety
PTSD
Migraines & Headaches
CRPS & Chronic Pain
Immunity & Resilience

Our Services:

IV Ketamine
Spravato (intranasal Ketamine)
Stellate Ganglion Blocks (SGB)
IV Nutrients & Vitamins
IV NAD+
IV Glutathione
Ketamine Assisted Psychotherapy (KAP)
Life Skills Coaching

Let us help you support your patients!

We pride ourselves on offering our patients a process that is administratively efficient and clinically rigorous while maintining a high level of personalized care and attention.

Step 1: Confirm Your Patient's Interest

The first step is to confirm your patient's openness/interest in infusion therapies such as Ketamine, NAD+, Vitamins, Glutathione, etc. by having a conversation with the differences between Combination Infusion Therapy and conventional approaches to treating anxiety, depression and PTSD.

Step 2: Submit Online Patient Referral Form

If you believe your patient may be a good fit for guided Ketamine treatments, then please tell us a little about them so we may contact them. You can submit a Patient Referral Form here.

Step 3: Review Patient Care Plan With Us

Once we have spoken with your patient and received required documents, we will contact you to confirm/discuss our treatment plan. We value your input and experience and will work closely with you to ensure the best patient care possible.

Step 4: We Provide Ongoing Updates About Treatments and Progress

With your patient's consent, we will share treatment information with you in order to keep you informed of their progress.

Research Papers

Yale University School of Medicine: Ketamine for Depression

October 5, 2012

A notable recent discovery shows that ketamine, a N-methyl-D-aspartate receptor antagonist, produces rapid (within hours) antidepressant responses in patients who are resistant to typical antidepressants.

Ketamine Treats Patients with Complex Regional Pain Syndrome Type 1

June 18, 2012

Complex Regional Pain Syndrome Type 1 (CRPS-1) responds poorly to standard pain treatment. We evaluated if the N-methyl-D-aspartate receptor antagonist S(+)-ketamine improves pain in CRPS-1 patients.

Duke University: Ketamine for Patients with Complex Regional Pain Syndrome

January 6, 2012

Despite being a recognized clinical entity for over 140 years, complex regional pain syndrome (CRPS) remains a difficult-to-treat condition.

How NAD+ Affects Wistar Rats

April 26, 2011

The cofactor nicotinamide adenine dinucleotide (NAD+) has emerged as a key regulator of metabolism, stress resistance and longevity.

Drexel University: Ketamine for Complex Regional Pain Syndrome

August 18, 2009

This randomized double-blind placebo controlled trial was designed to evaluate the effectiveness of intravenous ketamine in the treatment of CRPS.

Cooper University Hospital: Ketamine for Complex Regional Pain Syndrome

February 28, 2005

Complex Regional Pain Syndrome Type 1 (CRPS-1) responds poorly to standard pain treatment. We evaluated if the N-methyl-D-aspartate receptor antagonist S(+)-ketamine improves pain in CRPS-1 patients.

Can Ketamine Treat Complex Regional Pain Syndrome?

January 6, 2004

The purpose of this study was to ascertain if indeed the use of subanesthetic inpatient infusions of ketamine provide meaningful improvements in pain scores, and thus, quality of life, in patients suffering from CRPS.

MIT: What Does NAD+ Do?

January 6, 2003

Nicotinamide adenine dinucleotide (NAD) is a ubiquitous biological molecule that participates in many metabolic reactions. Recent studies show that NAD also plays important roles in transcriptional regulation, longevity, calorie-restrictionmediated life-span extension and age-associated diseases.

« Previous
1
…
6
7
8